Crossmark

Clinical outcomes of anti-inflammatory therapies inhibiting the NLRP3/IL-1β/IL-6/CRP pathway in coronary artery disease patients: a systemic review and meta-analysis of 37,056 individuals from 32 randomized trials

Crossref DOI link: https://doi.org/10.1007/s00011-025-02058-9

Published Online: 2025-06-30

Published Print: 2025-12

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Pan, Yannan

Fan, Fangfang

Jiang, Jie

Zhang, Yan
Funding

Funding for this research was provided by:

National Key R&D Program of China (2022YFE0209900)

National Key Research and Development Program of China (2021YFC2500503)

National High Level Hospital Clinical Research Funding (2022CR71)
License Information

Text and Data Mining valid from 2025-06-30

Version of Record valid from 2025-06-30
More Information

Article History

Received: 6 January 2025

Revised: 17 May 2025

Accepted: 21 May 2025

First Online: 30 June 2025

Declarations

:

: The authors declare no competing interests.

: Not applicable.

: Not applicable.

Document is current

Any future updates will be listed below